Perkembangan Diagnosis dan Tatalaksana Infeksi Mycoplasma genitalium
DOI:
https://doi.org/10.55175/cdk.v47i8.584Kata Kunci:
Infeksi, Mycoplasma genitalium, resistensiAbstrak
Mycoplasma genitalium adalah organisme penyebab infeksi menular seksual dengan prevalensi pada populasi risiko tinggi sekitar 10-41% pada laki - laki dan 7,3-14% pada perempuan. Mycoplasma genitalium menjadi penyebab sekitar 15-20% kasus uretritis non spesifik pada laki - laki dan 30% menyebabkan uretritis persisten atau rekuren. Infeksi M. genitalium dapat asimtomatik atau dengan gejala. Pada tahun 2019, US Food and Drug Administration menetapkan Aptima Mycoplasma genitalium Assay sebagai tes amplifikasi asam nukleat pertama yang diautorisasi untuk mendeteksi M. genitalium. Tes yang akurat dan spesifik berperan penting dalam pemilihan terapi, yang dapat membantu mengurangi penggunaan antibiotik berlebihan dan membantu melawan resistensi antibiotik.
Mycoplasma genitalium is a sexually transmited bacterium with 10-41% prevalence in men and 7,3-14% in women in the high risk population. Mycoplasma genitalium is responsible for 15-20% non specific urethritis in men and cause of 30% persistent or recurrent urethritis. Aptima Mycoplasma genitalium Assay is the first FDA authorized nucleic acid amplification test to detect M.genitalium. Accurate and reliable tests to identify specific bacteria can lead to the appropriate treatment, reduce antibiotics overuse and antimicrobial resistance
Unduhan
Referensi
Taylor-Robinson D, Tully JG, Furr PM, Cole RM, Rose DL, Hanna NF. Urogenital mycoplasma infections of man: A review with observations on a recently discovered mycoplasma. Isr J Med Sci. 1981; 17:524-30.
Jensen JS, Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis. 2015; 15:343.
Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: A meta-analysis. Clin Infect Dis. 2015. 61:418-26.
Hilton J, Azariah S, Reid M. A case-control study of men with non-gonococcal urethritis at Auckland Sexual Health Service: rates of detection of Mycoplasma genitalium. Sex Health. 2010; 7:77-81.
Wikström A, Jensen JS. Mycoplasma genitalium: A common cause of persistent urethritis among men treated with doxycycline.Sex Transm Infect.2016; 82:276-9.
Taylor-Robinson D. Mycoplasma genitalium - An up-date. Int J STD & AIDS.. 2012; 13:145-51.
Hamasuna R, Imai H, Tsukino H, Jensen JS, Osada Y. Prevalence of Mycoplasma genitalium among female students in vocational schools in Japan. Sex Transm Infect. 2011; 84:303-5
Wiesenfeld HC, Manhart LE. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen. J Infect Dis. 2017; 216:389-93.
Manhart LE. Mycoplasma genitalium: An emergent sexually transmitted disease? Infect Dis Clin N Am. 2013; 27:779-92.
British Association of Sexual Health and HIV. BASHH launches new nice accredited guidelines to help prevent mycoplasma genitalium becoming the next superbug, but funding cuts may hinder implementation. Tersedia dalam https://www.bashh.org/news/news/bashh-launches-new-nice-accredited-guidelines-to-help-prevent-mycoplasma-genitalium-becoming-the-next-superbug-but-funding-cuts-may-hinder-implementation/. 2018. Diakses pada 29 Februari 2020.
Widaty S, Soebono H, Nilasari H, Listiawan Y, Siswati A, Triwahyudi D, dkk, editor. Panduan Praktik Klinis. Jakarta: PP PERDOSKI. 2017; 359-60.
Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30:1650-6.
Chrisment D, Machelart I, Wirth G, Lazaro E, Greib C, Pellegrin J, Peuchant O. reactive arthritis associated with Mycoplasma genitalium urethritis. Diagn Micr Infec Dis J. 2013;77:278-9.
Soni S, Horner P, Rayment M, Pinto-Sander N, Naous N, Parkhouse A, dkk. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium. Int J STD & AIDS. 2019; 30:202-9.
Gaydos CA. Mycoplasma genitalium: accurate diagnosis is necessary for adequate treatment. J Infect Dis. 2017;216:406-11.
FDA permits marketing of first test to aid in the diagnosis of a sexually-transmitted infection known as Mycoplasma genitalium | FDA [Internet]. [cited 2019 Sep 9]. Available from: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-test-aid-diagnosis-sexually-transmitted-infection-known-mycoplasma
Daili S, Nilasari H, Indriatmi W, Zubier F, Rowawi R, Pudjiati SR. Infeksi Menular Seksual. Edisi ke-5. Jakarta: Balai Penerbit FKUI. 2017; 359–60.
Antibiotic Expert Groups. Genital and sexually transmitted infections. Dalam: Therapeutic Guidelines : Antibiotic. 15th ed. Melbourne(Australia): Therapeutic Guidelines Limited. 2014; 439–67.
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Reports. 2015;64:137.
Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FYS, dkk. The efficacy of azithromycin for the treatment of genital mycoplasma genitalium: A systematic review and meta-analysis. Clin Infect Dis. 2015;61:1389-99.
Dumke R, Thürmer A, Jacobs E. Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany. Diagn Microbiol Infect Dis. 2016;86:221-3.
Gesink D, Sarai Racey C, Seah C, Zittermann S, Mitterni L, Juzkiw J, dkk. Mycoplasma genitalium in Toronto, Ontario: Estimates of prevalence and macrolide resistance. Can Fam Physician. 2016;62:96-101.
Getman D, Jiang A, O’Donnell M, Cohen S. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol. 2016; 54:2278-83.
Couldwell DL, Tagg KA, Jeoffreys NJ, Gilbert GL. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD & AIDS. 2013; 24:822-8.
Kikuchi M, Ito S, Yasuda M, Tsuchiya T, Hatazaki K, Takanashi M, dkk. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother. 2014; 69:2376-82.
Read TRH, Jensen JS, Fairley CK, Grant M, Danielewski JA, Su J, dkk. Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection. Emerg Infect Dis. 2018; 24: 344-7.
Takahashi S, Hamasuna R, Yasuda M, Ito S, Ito K, Kawai S, dkk. Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother. 2013; 19:941-5.
Falk L, Jensen JS. Successful outcome of macrolide resistant Mycoplasma genitalium urethritis after spectinomycin treatment: A case report. J Antimicrob Chemother. 2017;72:624-5
Hook EW, Golden M, Jamieson BD, Dixon PB, Harbison HS, Lowens S, dkk. A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea. Clin Infect Dis. 2015; 61:1043-8.
Damiao AC, Unema M, Jensen JS. In vitro activity of zoliflodacin (ETX0914) against macrolide resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains. J Antimicrob Chemother. 2018;73:1291-4.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2020 https://creativecommons.org/licenses/by-nc/4.0/
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
